Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

234 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Intratracheal Budesonide Mixed With Surfactant for Extremely Preterm Infants: The PLUSS Randomized Clinical Trial.
Manley BJ, Kamlin COF, Donath SM, Francis KL, Cheong JLY, Dargaville PA, Dawson JA, Jacobs SE, Birch P, Resnick SM, Schmölzer GM, Law B, Bhatia R, Bach KP, de Waal K, Travadi JN, Koorts PJ, Berry MJ, Lui K, Rajadurai VS, Chandran S, Kluckow M, Cloete E, Broom MM, Stark MJ, Gordon A, Kodur V, Doyle LW, Davis PG, McKinlay CJD; PLUSS Trial Investigators. Manley BJ, et al. Among authors: cheong jly. JAMA. 2024 Nov 11:e2417380. doi: 10.1001/jama.2024.17380. Online ahead of print. JAMA. 2024. PMID: 39527075
Intratracheal budesonide mixed with surfactant to increase survival free of bronchopulmonary dysplasia in extremely preterm infants: study protocol for the international, multicenter, randomized PLUSS trial.
Manley BJ, Kamlin COF, Donath S, Huang L, Birch P, Cheong JLY, Dargaville PA, Dawson JA, Doyle LW, Jacobs SE, Wilson R, Davis PG, McKinlay CJD. Manley BJ, et al. Among authors: cheong jly. Trials. 2023 May 9;24(1):320. doi: 10.1186/s13063-023-07257-5. Trials. 2023. PMID: 37161488 Free PMC article.
Two-Year Outcomes After Minimally Invasive Surfactant Therapy in Preterm Infants: Follow-Up of the OPTIMIST-A Randomized Clinical Trial.
Dargaville PA, Kamlin COF, Orsini F, Wang X, De Paoli AG, Kanmaz Kutman HG, Cetinkaya M, Kornhauser-Cerar L, Derrick M, Özkan H, Hulzebos CV, Schmölzer GM, Aiyappan A, Lemyre B, Kuo S, Rajadurai VS, O'Shea J, Biniwale M, Ramanathan R, Kushnir A, Bader D, Thomas MR, Chakraborty M, Buksh MJ, Bhatia R, Sullivan CL, Shinwell ES, Dyson A, Barker DP, Kugelman A, Donovan TJ, Goss KCW, Tauscher MK, Murthy V, Ali SKM, Clark HW, Soll RF, Johnson S, Cheong JLY, Carlin JB, Davis PG; OPTIMIST-A Trial Investigators. Dargaville PA, et al. Among authors: cheong jly. JAMA. 2023 Sep 19;330(11):1054-1063. doi: 10.1001/jama.2023.15694. JAMA. 2023. PMID: 37695601 Free PMC article. Clinical Trial.
Intratracheal budesonide mixed with surfactant to increase survival free of bronchopulmonary dysplasia in extremely preterm infants: statistical analysis plan for the international, multicenter, randomized PLUSS trial.
Francis KL, McKinlay CJD, Kamlin COF, Cheong JLY, Dargaville PA, Dawson JA, Doyle LW, Jacobs SE, Davis PG, Donath SM, Manley BJ. Francis KL, et al. Among authors: cheong jly. Trials. 2023 Nov 6;24(1):709. doi: 10.1186/s13063-023-07650-0. Trials. 2023. PMID: 37932774 Free PMC article. Clinical Trial.
Changing outcomes for infants born extremely preterm.
Doyle LW, Cheong JLY. Doyle LW, et al. Among authors: cheong jly. Semin Perinatol. 2021 Dec;45(8):151475. doi: 10.1016/j.semperi.2021.151475. Epub 2021 Aug 21. Semin Perinatol. 2021. PMID: 34454741 No abstract available.
234 results